Operating Lease, Payments in USD of Keros Therapeutics, Inc. from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Keros Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and change rate from 2019 to 2024.
  • Keros Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $500K, a 150% increase year-over-year.
  • Keros Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $3.03M, a 170% increase from 2023.
  • Keros Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.12M, a 22.9% increase from 2022.
  • Keros Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $913K, a 55.5% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Keros Therapeutics, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $500K +$300K +150% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q1 2022 $200K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04

Keros Therapeutics, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.03M +$1.9M +170% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 $1.12M +$209K +22.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 $913K +$326K +55.5% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 $587K +$119K +25.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $468K +$190K +68.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $278K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.